-
CAREGIVER PRODUCTIVITY LOSS AND HEALTH-RELATED QUALITY OF LIFE ASSOCIATED WITH PEDIATRIC RESPIRATORY SYNCYTIAL VIRUS INFECTION IN KOREA
Mar 18, 2026, 21:38 PM -
NATIONWIDE COVID-19 TESTING PATTERNS AND DISPARITIES IN POSITIVITY AND ANTIVIRAL TREATMENT IN A U.S. RETAIL PHARMACY CHAIN, SEPTEMBER-DECEMBER 2025
Mar 18, 2026, 21:38 PM -
UNCOVERING EVIDENCE GAPS IN THE CLINICAL, ECONOMIC, AND HUMANISTIC IMPACT OF DUCHENNE MUSCULAR DYSTROPHY: A COMPREHENSIVE LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
HOW REPRESENTATIVE ARE LICENSABLE DATASETS COMPARED TO THEIR SOURCE POPULATION
Mar 18, 2026, 21:38 PM -
METHODOLOGICAL CHARACTERISTICS OF PHARMACOGENOMICS-INTEGRATED AI CLINICAL DECISION SUPPORT SYSTEMS (AI-CDSS): A SYSTEMATIC REVIEW
Mar 18, 2026, 21:38 PM -
TEPROTUMUMAB VERSUS INTRAVENOUS METHYLPREDNISOLONE ALONE, AND IN COMBINATION WITH MYCOPHENOLATE MOFETIL, FOR MODERATE-TO-SEVERE ACTIVE THYROID EYE DISEASE: A MATCHING-ADJUSTED INDIRECT COMPARISON
Mar 18, 2026, 21:38 PM -
FROM RETRIEVAL TO VERDICT: A HYBRID LLM PIPELINE FOR EVALUATING MEDICAL AND ECONOMIC CLAIMS
Mar 18, 2026, 21:38 PM -
INFLUENCING FACTORS ON THE APPROVAL LAG FOR INNOVATIVE DRUGS IN CHINA
Mar 18, 2026, 21:38 PM -
PREDICTING PROSTATE CANCER INCIDENCE USING A LARGE, NATIONAL U.S. ELECTRONIC HEALTH RECORDS (EHR) DATABASE
Mar 18, 2026, 21:38 PM -
EPIDEMIOLOGY AND TREATMENT PATTERNS OF THRYOID EYE DISEASE IN SPAIN: POPULATION-BASED REAL-WORLD EVIDENCE
Mar 18, 2026, 21:38 PM -
TRANSPARENCY OF CHARLSON COMORBIDITY INDEX (CCI) CODE DEFINITIONS IN REAL-WORLD RESEARCH: A SYSTEMATIC REVIEW
Mar 18, 2026, 21:38 PM -
THE ECONOMIC BURDEN ON FAMILIES OF CHILDREN WITH TYPE 1 SPINAL MUSCULAR ATROPHY IN BRAZIL
Mar 18, 2026, 21:38 PM -
PROVISIONAL PRICING IN MEDICINE POLICY: GLOBAL BENCHMARKING
Mar 18, 2026, 21:38 PM -
IMPACT OF MEDICATION CLUSTERS ON POST-DISCHARGE ADVERSE DRUG EVENTS AND HEALTHCARE UTILIZATION AMONG OLDER ADULTS
Mar 18, 2026, 21:38 PM -
IMPACT OF COMORBIDITIES ON SELF-REPORTED QUALITY-OF-LIFE IN US ADULTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): A POOLED ANALYSIS OF THE 2016-2022 MEDICAL EXPENDITURE PANEL SURVEY (MEPS)
Mar 18, 2026, 21:38 PM -
A COST-UTILITY ANALYSIS OF TOCILIZUMAB PLUS METHOTREXATE VERSUS METHOTREXATE ALONEIN RHEUMATOID ARTHRITIS IN INDIA, USING THE MARKOV STATE TRANSITION MODEL
Mar 18, 2026, 21:38 PM -
SOCIAL MEDIA CONVERSATIONS ON IMMUNE CHECKPOINT INHIBITORS: TREATMENT EXPERIENCES, SAFETY, ACCESS, AND PATIENT PERSPECTIVES
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF SINGLE-DOSE HPV VACCINATION IN NEPAL:AN ECONOMIC EVALUATION
Mar 18, 2026, 21:38 PM -
CYP2D6-GUIDED OPIOID PRESCRIBING AND CLINICAL OUTCOMES IN CHRONIC PAIN: EVIDENCE FROM THE ADOPT PGX TRIAL LINKED TO MEDICARE AND MEDICAID CLAIMS
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF SILVER-CONTAINING DRESSING IN PATIENTS WITH DIABETIC FOOT ULCERS IN KOREA
Mar 18, 2026, 21:38 PM
